ResMed (RMD) Misses Q3 EPS by 2c
Tweet
Share
E-mail
Get Alerts RMD Hot Sheet
Price: $228.25 --0%
EPS Growth %: +5.5%
Financial Fact:
Total other income, net: -1.22M
Today's EPS Names:
ALZN, ASPU, USAU, More
EPS Growth %: +5.5%
Financial Fact:
Total other income, net: -1.22M
Today's EPS Names:
ALZN, ASPU, USAU, More
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q3 EPS of $2.37, $0.02 worse than the analyst estimate of $2.39. Revenue for the quarter came in at $1.3 billion versus the consensus estimate of $1.29 billion.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- RBC bullish on Kraft Heinz, sees return to growth in 2027
- Faraday Future says it regained Nasdaq compliance after equity shortfall
- Icon Energy raises Q3 daily hire rate 23% year over year
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
